Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)

SHE:301258 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	495.14	361.68	224.73	349.74	259.69	332.06
Trading Asset Securities	625.45	899.07	1,123	1,070	1,161	21.61
Cash & Short-Term Investments	1,121	1,261	1,348	1,419	1,421	353.67
Cash Growth	-15.94%	-6.46%	-5.04%	-0.10%	301.69%	62.17%
Accounts Receivable	106.79	96.23	101.35	62.91	97.02	87.87
Other Receivables	0.63	0.68	0.84	0.93	0.85	2.05
Receivables	107.42	96.92	102.19	63.84	97.87	89.92
Inventory	136.69	132.45	154.83	157.09	122.69	68.6
Other Current Assets	20.97	19.7	6.75	8.59	8.55	4.41
Total Current Assets	1,386	1,510	1,612	1,649	1,650	516.6
Property, Plant & Equipment	539.83	524.72	398.91	387.62	416.11	421.15
Long-Term Investments	-	0.2	5	26.27	-	-
Other Intangible Assets	59.91	61.22	62.56	21.24	21.97	22.07
Long-Term Deferred Tax Assets	0.32	0.33	0.07	0.01	0	1.61
Long-Term Deferred Charges	-	2.01	3.28	4.55	-	-
Other Long-Term Assets	12.99	21.6	6.34	27.58	10.49	8.88
Total Assets	1,999	2,120	2,088	2,116	2,098	970.31

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	121.9	173.27	118.25	84.97	114.86	124.96
Accrued Expenses	15.01	20.91	19.62	19.48	18.47	17.85
Short-Term Debt	-	-	-	-	-	18.58
Current Portion of Leases	-	0.71	0.66	0.59	0.56	-
Current Income Taxes Payable	4.2	-	4.49	1.33	3.4	3.9
Current Unearned Revenue	0.95	2.26	1.42	2.07	6.49	6.73
Other Current Liabilities	0.78	0.86	0.81	3.66	6.12	1.15
Total Current Liabilities	142.86	198.01	145.25	112.1	149.91	173.17
Long-Term Leases	-	0.3	1.01	1.67	2.25	-
Long-Term Unearned Revenue	34.84	34.13	36.99	35.27	38.38	36.42
Long-Term Deferred Tax Liabilities	14.04	22.88	17.6	21.41	21.21	17.88
Total Liabilities	191.73	255.33	200.84	170.45	211.75	227.47

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	91.67	91.67	91.67	91.67	91.67	68.75
Additional Paid-In Capital	1,144	1,144	1,144	1,144	1,144	163.42
Retained Earnings	670.21	727.79	671.75	710.32	651.31	510.67
Treasury Stock	-98.51	-98.51	-20.14	-	-	-
Shareholders' Equity	1,807	1,865	1,887	1,946	1,887	742.84
Total Liabilities & Equity	1,999	2,120	2,088	2,116	2,098	970.31

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	-	1.01	1.67	2.25	2.82	18.58
Net Cash (Debt)	1,121	1,260	1,346	1,417	1,418	335.09
Net Cash Growth	-15.87%	-6.42%	-5.00%	-0.06%	323.12%	53.65%
Net Cash Per Share	12.59	13.91	14.77	15.41	16.47	4.88
Filing Date Shares Outstanding	88.59	88.59	90.82	91.67	91.67	68.75
Total Common Shares Outstanding	88.59	88.59	90.82	91.67	91.67	68.75
Working Capital	1,243	1,312	1,466	1,537	1,500	343.43
Book Value Per Share	20.40	21.05	20.78	21.22	20.58	10.80
Tangible Book Value	1,747	1,803	1,824	1,924	1,865	720.76
Tangible Book Value Per Share	19.72	20.36	20.09	20.99	20.34	10.48
Buildings	-	254.35	254.18	253.42	251.56	253.49
Machinery	-	475.96	470.51	454.95	436.91	384.41
Construction In Progress	-	199.38	38.15	1.49	0.43	12.17
Order Backlog	-	61.54	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Oct 22, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error